Geneos Wealth Management’s Invesco Preferred ETF PGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.38M Sell
310,360
-50,471
-14% -$570K 0.08% 270
2025
Q4
$4.06M Sell
360,831
-8,463
-2% -$96.5K 0.1% 238
2025
Q3
$4.28M Sell
369,294
-4,481
-1% -$51.3K 0.11% 225
2025
Q2
$4.16M Sell
373,775
-403,404
-52% -$4.45M 0.1% 247
2025
Q1
$8.72M Buy
777,179
+403,013
+108% +$4.66M 0.13% 194
2024
Q4
$4.31M Buy
374,166
+854
+0.2% +$10.3K 0.15% 160
2024
Q3
$4.61M Sell
373,312
-2,418
-0.6% -$28.9K 0.18% 140
2024
Q2
$4.34M Buy
375,730
+104,668
+39% +$1.21M 0.19% 124
2024
Q1
$3.22M Buy
271,062
+29,599
+12% +$349K 0.15% 176
2023
Q4
$2.77M Buy
241,463
+6,636
+3% +$72.4K 0.14% 179
2023
Q3
$2.57M Buy
234,827
+10,942
+5% +$122K 0.13% 178
2023
Q2
$2.55M Buy
223,885
+30,858
+16% +$350K 0.13% 179
2023
Q1
$2.22M Buy
193,027
+615
+0.3% +$7.38K 0.13% 179
2022
Q4
$2.15M Buy
192,412
+18,725
+11% +$217K 0.13% 171
2022
Q3
$2.06M Buy
173,687
+44
+0% +$554 0.14% 157
2022
Q2
$2.16M Buy
173,643
+27,348
+19% +$344K 0.11% 203
2022
Q1
$1.99M Buy
146,295
+22,802
+18% +$318K 0.09% 226
2021
Q4
$1.85M Buy
123,493
+12,294
+11% +$183K 0.07% 265
2021
Q3
$1.67M Buy
111,199
+9,165
+9% +$139K 0.06% 275
2021
Q2
$1.56M Sell
102,034
-18,858
-16% -$285K 0.06% 273
2021
Q1
$1.82M Buy
120,892
+5,213
+5% +$77.5K 0.05% 303
2020
Q4
$1.28M Buy
115,679
+49,176
+74% +$738K 0.05% 296
2020
Q3
$977K Buy
66,503
+9,900
+17% +$145K 0.05% 290
2020
Q2
$799K Buy
56,603
+654
+1% +$9.16K 0.04% 321
2020
Q1
$721K Sell
55,949
-4,584
-8% -$65.9K 0.05% 310
2019
Q4
$907K Sell
60,533
-4,167
-6% -$62.2K 0.05% 315
2019
Q3
$967K Buy
64,700
+16,020
+33% +$238K 0.06% 281
2019
Q2
$712K Buy
48,680
+16,986
+54% +$248K 0.04% 334
2019
Q1
$459K Buy
31,694
+5,545
+21% +$78.9K 0.03% 418
2018
Q4
$348K Sell
26,149
-6,216
-19% -$85.7K 0.03% 453
2018
Q3
$463K Buy
32,365
+6,994
+28% +$102K 0.03% 408
2018
Q2
$369K Buy
+25,371
New +$367K 0.03% 387

Other funds holding PGX

Geneos Wealth Management's PGX Position: Q1 2026 in Review

Geneos Wealth Management reduced its Invesco Preferred ETF (PGX) stake by 14% in Q1 2026, selling an estimated $570K and leaving 310,360 shares worth $3.38M. The position accounts for 0.08% of the portfolio, ranked #270.

Geneos Wealth Management first reported a position in PGX in Q2 2018 and has held it in 32 quarters since. The position peaked at $8.72M in Q1 2025. 413 funds tracked by Wall St. Rank hold PGX as of Q1 2026.

  • Geneos Wealth Management held 310,360 shares of Invesco Preferred ETF worth $3.38M as of Q1 2026.
  • Geneos Wealth Management sold 50,471 Invesco Preferred ETF shares in Q1 2026, an estimated $570K.
  • Invesco Preferred ETF made up 0.08% of Geneos Wealth Management's portfolio in Q1 2026, its #270 holding.
  • Geneos Wealth Management first reported a position in Invesco Preferred ETF in Q2 2018 and has held it in 32 quarters since.
  • Geneos Wealth Management's Invesco Preferred ETF position peaked at $8.72M in Q1 2025.
  • 413 funds tracked by Wall St. Rank held Invesco Preferred ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.